Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1128-2015

Drug recall · June 17, 2015

Alprostadil recall

Why: Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Alprostadil (PFE1), solution, 30 mcg/mL, injectable, 5 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT

Lots / codes

Lot 04062015:18@1. Expiry date: 8/1/2015

Quantity
1/5 mL vial
Company
Montana Compounding Pharmacy, Missoula, MT
Distribution
MT and ND
Initiated
May 15, 2015 · Voluntary: Firm initiated
Classified
June 9, 2015
Reported
June 17, 2015
Ended
December 20, 2016
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Alprostadil

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.